Fig. 6From: Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cellsEffect of eugenol treatment on the percentage of apoptotic MDA-MB-231 and SK-BR-3 cells. Cells were treated for 48 h with eugenol (4 and 8 μM, and 5 and 10 μM, respectively). The percentage of cells undergoing apoptosis was determined using annexin-V staining. Cells were immediately analyzed on the Muse™ Cell Analyzer (Merck KGaA Co., Darmstadt, Germany)Back to article page